title: Value Purchasing Programs Make Plodding Progress: Drug Manufacturers Question Some Pay-for-Performance Methodologies.
abstract: Escalating drug prices have seeded interest in value-based purchasing, but confusion and controversy have slowed the Centers for Medicare and Medicaid Services, state agencies, and private insurers from pursuing the potential savings.
authors.forename: Stephen
authors.initials: S
authors.lastname: Barlas